Six million Europeans suffer from atrial fibrillation, the most common heart rhythm disorder. This condition causes irregular and inefficient heart contractions, which can vary in duration from paroxysmal (lasting up to 48 hours or more than seven days) to chronic or permanent (continuous). Early detection and management are vital, as untreated atrial fibrillation can lead to severe complications such as stroke or heart failure.
Devices like the ZIVE ECG play a crucial role in monitoring and diagnosing atrial fibrillation. The ZIVE ECG is a certified medical device designed for continuous heart monitoring, making it possible to detect abnormal heart rhythms in real-time. Its advanced AI algorithms analyze the data, helping to identify over 20 heart-related issues, including atrial fibrillation. The device is user-friendly, comfortable to wear, and can monitor heart activity for up to seven days on a single charge. The data collected by ZIVE ECG can be shared with healthcare providers for further analysis and diagnosis, ensuring timely intervention and appropriate treatment.
Given the prevalence of atrial fibrillation and its potential risks, using a device like the ZIVE ECG can provide peace of mind and contribute significantly to heart health management. Regular monitoring with this device allows for early detection of irregularities, enabling proactive healthcare decisions that can prevent complications and improve long-term outcomes.